Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 46, 2022 - Issue 1: Special Issue: Thalassemia in Asia 2021
128
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam

, , , , , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 15-19 | Received 07 Oct 2021, Accepted 08 Oct 2021, Published online: 11 Aug 2022

References

  • Fucharoen S, Weatherall DJ. The hemoglobin E thalassemias. Cold Spring Harb Perspect Med. 2012;2(8):a011734–a011734.
  • Angastiniotis M, Lobitz S. Thalassemias: an overview. Int J Neonatal Screen. 2019;5(1):16.
  • Sabath DE. Molecular diagnosis of thalassemias and hemoglobinopathies: an ACLPS critical review. Am J Clin Pathol. 2017;148(1):6–15.
  • Kelly N. Thalassemia. Pediatr Rev. 2012;33(9):434–435.
  • Goonasekera HW, Paththinige CS, Dissanayake VHW. Population screening for Hemoglobinopathies. Annu Rev Genomics Hum Genet. 2018;19:355–380.
  • Sharma DC, Arya A, Kishor P, et al. Overview on thalassemias: a review article. Med Res Chronicles. 2017;4(3):325–337.
  • Old J. Hemoglobinopathies and thalassemias. In: Rimoin D, Pyeritz R, Korf B, Editors. Emery and Rimoin’s principles and practice of medical genetics. 6th ed. Oxford (MS, USA): Academic Press; 2013. p. 1–44.
  • Saeed U, Piracha ZZ. Thalassemia: impact of consanguineous marriages on most prevalent monogenic disorders of humans. Asian Pac J Trop Dis. 2016;6(10):837–840.
  • Sayahi M, Mardasi FG, Kambo MS. Thalassemia spectrum and prenatal diagnosis among voluntary couples in Shushtar City, during a five year period. Gene Cell Tissue. 2017;4(4):e64501.
  • Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Indian J Med Res. 2011;134(4):498–506.
  • Aggarwal R, Prakash A, Aggarwal M. Thalassemia: an overview. J Sci Soc. 2014;41(1):3–6.
  • Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis and treatment. Dtsch Arztebl Int. 2011;108(31-32):532–540.
  • Marengo-Rowe AJ. The thalassemias and related disorders. Proc (Bayl Univ Med Cent). 2007;20(1):27–31.
  • Ryan K, Bain B, Worthington D, et al., British Committee for Standards in Haematology. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010;149(1):35–49.
  • Trent RJA. Diagnosis of the hemoglobinopathies. Clin Biochem Rev. 2006;27(1):27–38.
  • Brancaleoni V, Di Pierro E, Motta I, Cappellini MD. Laboratory diagnosis of thalassemia. Int Jnl Lab Hem. 2016;38(Suppl 1):32–40.
  • Harris NS, Winter WE. Hemoglobinopathies: biochemical disorders of hemoglobin. In Clarke W, editor. Contemporary practice in clinical chemistry. 2nd ed. Washington (DC, USA): AACC Press; 2011. p. 249–263.
  • Steinberg MH. Sickle cell disease and other hemoglobinopathies. In: Goldman L, Schafer A, editors. Goldman’s Cecil medicine. 24th ed. Philadelphia (PA, USA): Elsevier; 2012. p. 1066–1075.
  • Kotila TR. Guidelines for the diagnosis of the haemoglobinopathies in Nigeria. Ann Ibadan Postgrad Med. 2010;8(1):25–29.
  • Lee YK, Kim H, Lee K, et al. Recent progress in laboratory diagnosis of thalassemia and hemoglobinopathy: a study by the Korean Red Blood Cell Disorder Working Party of the Korean Society of Hematology. Blood Res. 2019;54(1):17–22.
  • Rosatelli MC, Saba L. Prenatal diagnosis of β-thalassemias and hemoglobinopathies. Mediterr J Hematol Infect Dis. 2009;1(1):e2009011.
  • Gu X, Zeng Y. A review of the molecular diagnosis of thalassemia. Hematology. 2002;7(4):203–209.
  • Munkongdee T, Chen P, Winichagoon P, et al. Update in laboratory diagnosis of thalassemia. Front Mol Biosci. 2020;7:74.
  • Joshi D-D, Nickerson HJ, McManus MJ. Hydrops fetalis caused by homozygous alpha-thalassemia and Rh antigen alloimmunization: report of a survivor and literature review. Clin Med Res. 2004;2(4):228–232.
  • Ismail JB. Thalassaemia and haemoglobinopathies in Brunei Darussalam. Med J Malaysia. 1992;47(2):98–102.
  • Noori T, Ghazisaeedi M, Aliabad GM, et al. International comparison of thalassemia registries: challenges and opportunities. Acta Inform Med. 2019;27(1):58–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.